To Determine the Expression of SOX2 as a Diagnostic Marker in Early Detection of Oral Squamous Cell Carcinoma
- Suleman Roshan Medical College Tando Adam
- LUMHS, Jamshoro
- Muhammad Medical College Mirpurkhas
- Suleman Roshan Medical College (SRMC) Tando Adam
- LUMHS/ Jamshoro
- Mohammad Medical College Mirpurkhas
Abstract
Objective: To determine the expression of SOX2 in histological grades of Oral Squamous Cell Carcinoma (OSCC).
Methodology: This cross-sectional descriptive study was conducted at Department of Pathology and Oral Surgery, LUMHS Jamshoro/Hyderabad from October 2021 to September 2022. All the diagnosed cases of OSCC based on Histopathology laboratory of either age or gender were included. For each biopsy, three sections were prepared; two were stained with hematoxylin and eosin and one used for the immune-marker SOX2 and histopathological grading of OSCC was performed on the hematoxylin and eosin–stained slides according to WHO criteria. Data was analyzed with SPSS 22.0.
Results: The mean age of the patients was 44.82 years with male predominance 71.3%. Out of all, 22.5% cases had week tumor intensity, 21.9% had moderate tumor intensity and 55.65 cases had strong tumor intensity. In accordance to the expression of the SOX2, 28.1% cases had negative expression and 19.4% had low expression, while 52.5% cases had high expression. Most of the cases 87.5% had moderately differentiated OSCC, 6.9%. SOX2 expression was statistically insignificant according to gender (p=0.738), while it was statistically significant according to the tumor intensity and histological grading (p <0.05)
Conclusion: SOX2 expression has been identified as the most valuable indicator for diagnosing the oral squamous cell carcinoma and particularly advantageous for distinguishing disease prognosis.
Metrics
License
Copyright (c) 2026 Urooj, Ikram Din Ujjan, Kiran Memon, Maria Jawed, Sapna lohia, Faria Sana

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.